Baseline ¹⁸F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancer
about
Predicting the Response of Neoadjuvant Therapy for Patients with Esophageal Carcinoma: an In-depth Literature ReviewPrognostic Value of Volume-Based Metabolic Parameters Measured by (18)F-FDG PET/CT of Pancreatic Neuroendocrine Tumors.Prognostic impact of [18F]fluorothymidine and [18F]fluoro-D-glucose baseline uptakes in patients with lung cancer treated first-line with erlotinib.Radiobiological Modeling Based on (18)F-Fluorodeoxyglucose Positron Emission Tomography Data for Esophageal Cancer.Predicting Response to Neoadjuvant Chemotherapy with PET Imaging Using Convolutional Neural Networks.Predictive value of initial FDG-PET features for treatment response and survival in esophageal cancer patients treated with chemo-radiation therapy using a random forest classifier.Impact of partial-volume effect correction on the predictive and prognostic value of baseline 18F-FDG PET images in esophageal cancer.Impact of tumor size and tracer uptake heterogeneity in (18)F-FDG PET and CT non-small cell lung cancer tumor delineationPrognostic value of volume-based (18)F-fluorodeoxyglucose PET/CT parameters in patients with clinically node-negative oral tongue squamous cell carcinoma.FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinomaEarly prediction of pathological response in locally advanced rectal cancer based on sequential 18F-FDG PET.Prognostic Significance of 2-Deoxy-2-[18F]-Fluoro-D-Glucose PET/CT in Patients With Locally Advanced Esophageal Cancer Undergoing Neoadjuvant Chemoradiotherapy Before Surgery: A Nonparametric Approach.Morphologic and Metabolic Comparison of Treatment Responsiveness with 18Fludeoxyglucose-Positron Emission Tomography/Computed Tomography According to Lung Cancer Type.Monitoring tumour response during chemo-radiotherapy: a parametric method using FDG-PET/CT images in patients with oesophageal cancer.The age of reason for FDG PET image-derived indices.Texture analysis of 18F-FDG PET/CT to predict tumour response and prognosis of patients with esophageal cancer treated by chemoradiotherapy.PETSTEP: Generation of synthetic PET lesions for fast evaluation of segmentation methods.PET/CT-based metabolic tumour volume for response prediction of neoadjuvant chemoradiotherapy in oesophageal carcinoma.Robustness of intratumour ¹⁸F-FDG PET uptake heterogeneity quantification for therapy response prediction in oesophageal carcinoma.Standardized added metabolic activity (SAM): a partial volume independent marker of total lesion glycolysis in liver metastases.Initial FDG-PET/CT predicts survival in adults Ewing sarcoma family of tumors.A multifractal approach to space-filling recovery for PET quantification.Personalized therapy based on image for esophageal or gastroesophageal junction adenocarcinoma.Pretreatment metabolic tumour volume is predictive of disease-free survival and overall survival in patients with oesophageal squamous cell carcinoma.Prognostic and predictive value of metabolic tumor volume on (18)F-FDG PET/CT in advanced biliary tract cancer treated with gemcitabine/oxaliplatin with or without erlotinib.Prognostic value of pretreatment ¹⁸F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma.
P2860
Q26777898-0B3B857D-81F5-45A5-AD4A-441E1F529CDAQ34090931-1345AC5B-AC5E-4F99-B7A7-42CDEA2964B2Q34544677-18E50D97-9CD8-4D34-83A7-D3FC2A18A57FQ34858176-33B2C160-D738-4A71-A4D7-F9065EC40BD4Q35768828-5E946CED-C33B-4AD7-A35E-DDC0F01C48DBQ36304217-46418E8B-AF84-46F8-A9B3-81276C2E3BFFQ36335078-6B526247-A8F6-4815-804F-E141F4A3409BQ36350466-3162FA65-141F-4DE4-9B1E-66539CCDA761Q36357282-CBB9FAEB-4EAF-4340-A802-0C3F9890E2C4Q36655475-8C44EF1E-3964-4536-8FB8-0418B8F27887Q36918459-967CDEEF-6201-4A38-BA70-FB26F69FF36BQ37205872-971223DE-27C3-4BD1-8A4C-A36ED76ED66FQ37395352-2A10AD6C-3BCD-452D-B95D-F02182204253Q37681293-9DB2223D-5E67-4E77-94E0-AFBE74382CC2Q39065889-2B0E8ABD-B78A-4DB8-8039-5163992857FFQ39405075-763A1B09-94F3-47FA-8786-AF3716CAFC0EQ40309445-46AD5AA7-95CE-4DBA-AAC5-16BF3C040610Q43582196-146849E5-8F54-47EB-B163-B705070B9EF7Q43753631-691CAF56-13E1-496E-A7F1-0482FC9A8330Q43919851-2F46943C-5F95-4FA4-A939-27C9EDCE4C08Q47119469-78BED764-6A50-4C5A-98C8-4A673C4D3410Q48813461-7DE8FAC9-B4E3-4D36-8E07-3EF6A6C63000Q52581750-DED005EE-EF3D-4318-923A-F7C9C25A6641Q53059540-F034DCBF-ACE8-407E-B58E-E73EAD7DC449Q53063502-D67F2A85-8DA9-49EC-9D39-A8BE468CDE11Q54298531-FE707293-0FA9-4B8D-9AAE-2178967504D5
P2860
Baseline ¹⁸F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancer
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Baseline ¹⁸F-FDG PET image-der ...... ediction in oesophageal cancer
@ast
Baseline ¹⁸F-FDG PET image-der ...... ediction in oesophageal cancer
@en
type
label
Baseline ¹⁸F-FDG PET image-der ...... ediction in oesophageal cancer
@ast
Baseline ¹⁸F-FDG PET image-der ...... ediction in oesophageal cancer
@en
prefLabel
Baseline ¹⁸F-FDG PET image-der ...... ediction in oesophageal cancer
@ast
Baseline ¹⁸F-FDG PET image-der ...... ediction in oesophageal cancer
@en
P2093
P2860
P1476
Baseline ¹⁸F-FDG PET image-der ...... ediction in oesophageal cancer
@en
P2093
Catherine Cheze-le Rest
Dimitris Visvikis
Mathieu Hatt
Olivier Pradier
P2860
P2888
P304
P356
10.1007/S00259-011-1834-9
P577
2011-05-11T00:00:00Z